Focused Wealth Management’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-447
Closed -$3.71K 610
2023
Q4
$3.71K Hold
447
﹤0.01% 698
2023
Q3
$2.79K Hold
447
﹤0.01% 730
2023
Q2
$1.94K Hold
447
﹤0.01% 803
2023
Q1
$760 Hold
447
﹤0.01% 903
2022
Q4
$867 Hold
447
﹤0.01% 888
2022
Q3
$1K Buy
447
+150
+51% +$358 ﹤0.01% 864
2022
Q2
$1K Sell
297
-250
-46% -$621 ﹤0.01% 842
2022
Q1
$2K Buy
547
+47
+9% +$167 ﹤0.01% 791
2021
Q4
$2K Sell
500
-200
-29% -$945 ﹤0.01% 810
2021
Q3
$4K Hold
700
﹤0.01% 746
2021
Q2
$8K Sell
700
-5,205
-88% -$59.9K ﹤0.01% 649
2021
Q1
$93K Buy
5,905
+4,705
+392% +$84.7K 0.02% 287
2020
Q4
$8K Buy
+1,200
New +$8.8K ﹤0.01% 588

Other funds holding LFMD

Focused Wealth Management's LFMD Position: Q1 2024 in Review

Focused Wealth Management sold out of LifeMD (LFMD) in Q1 2024, closing a stake of 447 shares — an estimated $3.71K sold.

Focused Wealth Management first reported a position in LFMD in Q4 2020 and held it in 13 quarters. The position peaked at $93K in Q1 2021. 89 funds tracked by Wall St. Rank hold LFMD as of Q1 2024.

  • Focused Wealth Management reported no remaining LifeMD position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 447 LifeMD shares in Q1 2024, an estimated $3.71K.
  • Focused Wealth Management first reported a position in LifeMD in Q4 2020 and held it in 13 quarters.
  • Focused Wealth Management's LifeMD position peaked at $93K in Q1 2021.
  • 89 funds tracked by Wall St. Rank held LifeMD as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.